Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Advanced Non-Small Cell Lung Cancer × WW Domain-Containing Oxidoreductase × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Neoplasm Metastasis 1 Breast Neoplasms 1 Advanced Non-Small Cell Lung Cancer 1

Interventions

Docetaxel 3 nimotuzumab 1 WW Domain-Containing Oxidoreductase 1 Vinorelbine 1 Paclitaxel 1 Gene Expression Profiling 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Carboplatin 1 Capecitabine 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00064636 2005-06-24

Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Millennium Pharmaceuticals, Inc.

Phase 1 Terminated

Other solid neoplasmThoracic

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡